This page is historical material reflecting the Feedback Loop Blog as it existed on June 22, 2020. This page is no longer updated and links to external websites and some internal pages may not work.
June 22, 2020

Archived: NIGMS Priorities for Small Business Development of Sepsis Diagnostics and Therapeutics

By Sarah Dunsmore

Last summer, we published a notice of information on our priorities for sepsis research that applies to all active NIGMS funding opportunity announcements. We’ve now published a notice of special interest (NOT-GM 20-028) to promote early-stage research and development projects through the NIH SBIR/STTR program. 

We’re interested in receiving applications from small businesses or from small businesses and their academic partners that propose to develop novel tools and technologies for sepsis research, detection, and treatment. We’re specifically interested in diagnostic tools, predictive clinical algorithms, and technologies to facilitate molecular phenotyping of sepsis patients.

If you have any questions about NIGMS priorities for small business development of sepsis diagnostics and therapeutics, please contact me. 

topic Funding Opportunities , Research Administration
tag Sepsis Research

About the Author

Sarah Dunsmore

Sarah manages a variety of grants involving innate immunity, inflammation, and sepsis. She is the primary contact for information about NIGMS-funded sepsis research.